A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib
Conditions: Non Small Cell Lung Cancer Metastatic; ALK Gene Mutation Interventions: Drug: Lorlatinib Sponsors: Centro di Riferimento Oncologico - Aviano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Choline Metabolites in Men With Prostate Cancer and Those With Benign Hyperplasia
Conditions: Primary Prostate Urothelial Cancer; Benign Prostatic Hyperplasia Sponsors: Universit ät des Saarlandes Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer
Conditions: Locally Advanced Cervical Carcinoma; Concurrent Chemoradiotherapy; Immunotherapy Interventions: Radiation: Nab-paclitaxel/Platinum, Sintilimab Sponsors: RenJi Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Blastocystis and Cryptosporidium Infection in Colorectal Cancer Patients
Conditions: Blastocystis Infection; Cryptosporidium Infection; Colorectal Cancer Interventions: Diagnostic Test: ELISA / PCR Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations
Conditions: Local Advanced or Metastatic NSCLC Interventions: Drug: JMT101 Injection; Drug: Osimertinib tablet; Drug: Cisplatin injection; Drug: Pemetrexed injection Sponsors: Shanghai JMT-Bio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
Conditions: Non-Small Cell Lung Cancer Interventions: Drug: Anlotinib Hydrochloride Capsule; Drug: Tislelizumab Injection; Radiation: Hypofractionated Radiotherapy Sponsors: Ji Yongling Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC
Conditions: Colorectal Cancer Metastatic Interventions: Drug: Cetuximab; Drug: Trifluridine/Tipiracil Sponsors: Wangxia LV Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
Conditions: Endometrial Neoplasms; Atypical Endometrial Hyperplasia; Progesterone Resistance; Obesity Interventions: Drug: GnRH antagonist; Drug: Letrozole 2.5mg Sponsors: Xiaojun Chen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Colorectal Cancer
Conditions: Colorectal Cancer Interventions: Other: observational study, no intervention Sponsors: Zhujiang Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Skin Cancer Diagnostics Using Photoacoustic Imaging
Conditions: Skin Cancer Sponsors: Region Skane; Lund University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology
Conditions: Lung Cancer Interventions: Device: BioSpy System Sponsors: Sensome Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Cukurova Score Validation Study
Conditions: Epithelial Ovarian Cancer; Primary Cytoreduction Sponsors: Cukurova University; Mu ğla Sıtkı Koçman University; Sakarya University; Gazi University; Ankara Etlik City Hospital; Kayseri City Hospital; Mersin University; Selçuk University; Bezmialem Vakif University; Uludag University; Mersin City Hospital; Marmara University; Prof. Dr. Cemil Tascıoglu City Hospital; Ankara Un iversity; Ege University; Hacettepe University; Akdeniz University; Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital; Mustafa Kemal University; Trakya University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients
Conditions: Pancreatic Cancer Interventions: Other: no intervention Sponsors: Jinling Hospital, China Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
Conditions: Autologous Stem Cell Transplant; Classic Hodgkin Lymphoma Interventions: Drug: Pembrolizumab; Procedure: Autologous stem cell transplant; Drug: Carmustine; Drug: Etoposide; Drug: Cytarabine; Drug: Melphalan Sponsors: Masonic Cancer Center, University of Minnesota Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
FDA Approves Clinical Trial for GFH925 Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
SHANGHAI, April 19, 2024. GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 22, 2024 Category: Pharmaceuticals Source Type: clinical trials
